Pathophysiology of Resistant Hypertension: The Role of Sympathetic Nervous System
Open accessThe DOI matches its Crossref record; 35 of the 35 references it cites were found in a registry or an index.
Abstract
Resistant hypertension (RH) is a powerful risk factor for cardiovascular morbidity and mortality. Among the characteristics of patients with RH, obesity, obstructive sleep apnea, and aldosterone excess are covering a great area of the mosaic of RH phenotype. Increased sympathetic nervous system (SNS) activity is present in all these underlying conditions, supporting its crucial role in the pathophysiology of antihypertensive treatment resistance. Current clinical and experimental knowledge points towards an impact of several factors on SNS activation, namely, insulin resistance, adipokines, endothelial dysfunction, cyclic intermittent hypoxaemia, aldosterone effects on central nervous system, chemoreceptors, and baroreceptors dysregulation. The further investigation and understanding of the mechanisms leading to SNS activation could reveal novel therapeutic targets and expand our treatment options in the challenging management of RH.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Sympathetic neural mechanisms in obstructive sleep apnea.
Somers, V. K., Dyken, M. E., Clary, M. P., & Abboud, F. M. (1995) · Journal of Clinical Investigation · doi:10.1172/jci118235 · Cited by 2,527
Krum, H., Schlaich, M., Whitbourn, R., Sobotka, P. A., Sadowski, J., Bartus, K., Kapelak, B., Walton, A., Sievert, H., Thambar, S., et al. (2009) · The Lancet · doi:10.1016/s0140-6736(09)60566-3 · Cited by 2,108
High prevalence of unrecognized sleep apnoea in drug-resistant hypertension
Logan, A. G., Perlikowski, S. M., Mente, A., Tisler, A., Tkacova, R., Niroumand, M., Leung, R. S. T., & Bradley, T. D. (2001) · Journal of Hypertension · doi:10.1097/00004872-200112000-00022 · Cited by 960 · cited 1×
“In a series of 41 resistant hypertensives, the prevalence of OSA, diagnosed by overnight polysomnographic study, was 83% and both the prevalence and the severity were significantly higher in men than in women [19].”
BackgroundHyperaldosteronism Among Black and White Subjects With Resistant Hypertension
Calhoun, D. A., Nishizaka, M. K., Zaman, M. A., Thakkar, R. B., & Weissmann, P. (2002) · Hypertension · doi:10.1161/01.hyp.0000040261.30455.b6 · Cited by 763
Anderson, E. A., Sinkey, C. A., Lawton, W. J., & Mark, A. L. (1989) · Hypertension · doi:10.1161/01.hyp.14.2.177 · Cited by 632
Sympathetic Activation in Obese Normotensive Subjects
Grassi, G., Seravalle, G., Cattaneo, B. M., Bolla, G. B., Lanfranchi, A., Colombo, M., Giannattasio, C., Brunani, A., Cavagnini, F., & Mancia, G. (1995) · Hypertension · doi:10.1161/01.hyp.25.4.560 · Cited by 614 · cited 1×
“The further investigation and understanding of the mechanisms leading to SNS activation could reveal novel therapeutic targets and expand our treatment options in the challenging management of RH.”
BackgroundHuman muscle nerve sympathetic activity at rest. Relationship to blood pressure and age
Sundlöf, G., & Wallin, B. G. (1978) · The Journal of Physiology · doi:10.1113/jphysiol.1978.sp012170 · Cited by 601
Catecholamine metabolism: basic aspects and clinical significance.
Kopin, I. J. (1985) · Pharmacological Reviews · doi:10.1016/s0031-6997(25)06859-0 · Cited by 582
Rosenbaum, M. (2005) · Journal of Clinical Investigation · doi:10.1172/jci25977 · Cited by 575
Sympathetic Neural Activation in Visceral Obesity
Alvarez, G. E., Beske, S. D., Ballard, T. P., & Davy, K. P. (2002) · Circulation · doi:10.1161/01.cir.0000041244.79165.25 · Cited by 557 · cited 1×
“Finally, the distribution of the adipose tissue seems to be crucial for the activation of the SNS since the central pattern of obesity with excess of visceral fat is accompanied by increased MSNA in contrast to men with peripheral obesity where MSNA is no higher than in lean men [23, 28, 29].”
Background
Cited by
Pokushalov, E., Romanov, A., Corbucci, G., Artyomenko, S., Baranova, V., Turov, A., Shirokova, N., Karaskov, A., Mittal, S., & Steinberg, J. S. (2012) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2012.05.036 · Cited by 432
ESH Position Paper: Renal denervation – an interventional therapy of resistant hypertension
Schmieder, R. E., Redon, J., Grassi, G., Kjeldsen, S. E., Mancia, G., Narkiewicz, K., Parati, G., Ruilope, L., van de Borne, P., & Tsioufis, C. (2012) · Journal of Hypertension · doi:10.1097/hjh.0b013e328352ce78 · Cited by 241
“This is also the case for pregnancy-induced hypertension [23], some secondary types of hypertension [24] and resistant hypertension [25].”
BackgroundSelf-citationHering, D., Marusic, P., Walton, A. S., Lambert, E. A., Krum, H., Narkiewicz, K., Lambert, G. W., Esler, M. D., & Schlaich, M. P. (2014) · Hypertension · doi:10.1161/hypertensionaha.113.03098 · Cited by 142
Gut–Brain Axis in Regulation of Blood Pressure
Yang, T., & Zubcevic, J. (2017) · Frontiers in Physiology · doi:10.3389/fphys.2017.00845 · Cited by 74
“In addition to chronically elevated SNS activity (Tsioufis et al., 2011) accompanied by norepinephrine (NE) spillover (Tsioufis et al.”
BackgroundInfluentialSmith, S. M., Huo, T., Delia Johnson, B., Bittner, V., Kelsey, S. F., Vido Thompson, D., Noel Bairey Merz, C., Pepine, C. J., & Cooper‐DeHoff, R. M. (2014) · Journal of the American Heart Association · doi:10.1161/jaha.113.000660 · Cited by 69
Wang, C., Xiong, B., & Huang, J. (2016) · Heart, Lung and Circulation · doi:10.1016/j.hlc.2016.02.016 · Cited by 58
“Elevation of serum aldosterone, over-activity of mineralocorticoid receptors and sympathetic nervous system have been recognised to contribute to the pathogenesis of RH [21–23].”
BackgroundDiagnosis and management of resistant hypertension: state of the art
Wei, F.-F., Zhang, Z.-Y., Huang, Q.-F., & Staessen, J. A. (2018) · Nature Reviews Nephrology · doi:10.1038/s41581-018-0006-6 · Cited by 39
Metadata
- Authors
- Tsioufis, C., Kordalis, A., Flessas, D., Anastasopoulos, I., Tsiachris, D., Papademetriou, V., & Stefanadis, C.
- Venue
- International Journal of Hypertension
- Publisher
- Wiley
- Published
- 2011
- Volume
- 2011
- Pages
- 1-7
- ISSN
- 2090-0384 (ISSN-L)
- 2090-0392
- OpenAlex
- W2034163551
- Cited by
- 139
- References
- 35
- FWCI
- 10.66
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.